Johnson & Johnson (NYSE:JNJ) is pulling the plug on its troubled metal-on-metal hip implant business, effective Aug. 31. In a statement released by JNJ subsidiary DePuy Orthopaedics, the healthcare giant said it would halt all sales of its Ultamet metal-on-metal articulation and Complete ceramic-on-metal acetabular hip system because of lower physician adoption rates and a …read more.